Vyriad announced development of new antibody test to determine protective immunity from COVID-19
On May 14, 2020 Vyriad announced that it had completed the development of a serology test to measure…
The USDA announced the release of Three Joy peaches
On May 14, 2020, the USDA announced the Agricultural Research Service (ARS) has released a trio of Joy…
First detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine development
On May 14, 2020, scientists at La Jolla Institute for Immunology (LJI) announced they had resolved the uncertainty…
ViralClear publishesd in F1000 research in vitro data demonstrating synergy between merimepodib and remdesivir against SARS-CoV-2, the cause of COVID-19
On May 14, 2020, BioSig Technologies announced that an article titled, ﾓThe IMPDH inhibitor merimepodib provided in combination…
AIM ImmunoTech announced FDA authorization for first human ampligen trial in COVID-19 patients with cancer
On May 14, 2020, AIM ImmunoTech announced the FDA authorized the first human trial assessing the safety and…
BioMed X Institute launched rapid antiviral response platform to prevent future pandemics
On May 13, 2020, BioMed X, an independent Heidelberg-based research institute, announced the launch of its new Rapid…
Philips received FDA clearance for use of ultrasound portfolio to manage COVID-19-related lung and cardiac complications
On May 13, 2020, Royal Philips announced that it had received 510(k) clearance from the FDA to market…
Harvard-led initiative awarded over $165 million to support 62 COVID-19 research projects
On May 13, 2020, the Massachusetts Consortium on Pathogen Readiness (MassCPR), a multi-institutional initiative convened by Harvard Medical…
University of Nebraska developed a COVID-19 screening mobile app
On May 13, 2020, a new protective device that is expected to help protect healthcare workers everywhere from…
Catalent signed development agreement with Ennaid Therapeutics on its COVID-19 lead program
On May 13, 2020,Catalent announced a collaboration with Ennaid Therapeutics to develop an oral, antiviral treatment targeted at…
Immunic received regulatory approval from German Health Authority BfArM to initiate phase 2 clinical trial in COVID-19 patients
On May 13, 2020, Immunic announced it had received first regulatory approval from Germany’s BfArM to initiate a…
Abbott received FDA Emergency Use Authorization for COVID-19 Molecular Test on New Alinity mï¾™ System
On May 12, 2020, Abbott announced the FDA issued an Emergency Use Authorization (EUA) for the company’s molecular…
FDA further expanded EUA for Thermo Fisher Scientific’s COVID-19 diagnostic tests
On May 12, 2020, Thermo Fisher Scientific announced the FDA has further expanded emergency use authorization (EUA) for…
Combing through old drugs to find new ones for COVID-19
On May 12, 2020, the Broad Instituteï¾’s Drug Repurposing Hub announced that it had opened its repository of…
LabCorp significantly expanded availability of Its COVID-19 at-home collection test kit
On May 12, 2020, LabCorpï¾® announced that its COVID-19 at-home collection test kit is now being offered to…
Mylan to supply investigational antiviral remdesivir for potential treatment of COVID-19
On May 12, 2020, Mylan announced, as part of its ongoing efforts to support patients and public health…
The FDA announced actions to accelerate development of novel prevention, treatment options for COVID-19
On May 11, 2020, the FDA announced actions to accelerate the development of prevention and treatment options for…
NIH report coordinated strategy to accelerate multiple COVID-19 vaccine candidates is key
On May 11, 2020, a harmonized and collaborative approach to the clinical testing, scale-up and distribution of candidate…
U of Alberta pharmaceutical institute leads effort to fill looming hospital drug shortage during fight against COVID-19
On May 11, 2020, a University of Alberta-initiated institute leads province wide effort to fill the looming shortage…
SARS-CoV-2 targets many cell types, analysis of single-cell data suggests
On May 11, 2020, HHMI announced that scientists had identified places the new coronavirus, called SARS-CoV-2, may invade…
NanoViricides developed highly effective broad-spectrum drug candidates against Coronaviruses
On May 11, 2020, NanoViricides announced it had developed drug candidates demonstrated very high anti-viral effectiveness in cell…
Thermo Fisher Scientific to double its capacity of viral vector manufacturing
On May 11, 2020, Thermo Fisher Scientific announced it is expanding capacity for viral vector development and manufacturing…
NIH clinical trial testing antiviral remdesivir plus antiiInflammatory drug baricitinib for COVID-19 began
On May 8, 2020, the NIH announced that a randomized, controlled clinical trial evaluating the safety and efficacy…
The FDA issued EUA for first diagnostic test using at-home collection of saliva specimens
On May 8, 2020, the FDA issued an emergency use authorization (EUA) to Rutgers Clinical Genomics Laboratory for…
Bharat Biotech leads a CSIR-NMITLI supported project to develop human antibodies or COVID-19 therapy
On May 8, 2020, the Council of Scientific and Industrial Research (CSIR) under its flagship programme NMITLI announced…
OPKO Health’s BioReference Laboratories launched COVID-19 antibody screening for New York City residents
On May 8, 2020, BioReference Laboratories, an OPKO Health company, announced the launch of COVID-19 antibody screening available…
The Defense Health Agency collaborated to further sequence the SARS-CoV-2 code
On May 7, 2020, the Defense Health Agency announced that the Air Force Genetics Center of Excellence at…
NIH-supported research examines impact of COVID-19 on rare diseases community
On May 7, 2020, the NIH announced a new online survey launched by the NIH-supported Rare Diseases Clinical…
Risk factors for COVID-19 death revealed in worldï¾’s largest analysis of patient records to date
On May 7, 2020, academics at the University of Oxford and the London School of Hygiene & Tropical…
Sanger scientist received Chan Zuckerberg Initiative support for COVID-19 study
On May 7, 2020, the Wellcome Sanger Institute announced that Roser Vento-Tormo, a Group Leader was one of…